Keynote Financial Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.76M Sell
14,604
-35
-0.2% -$4.04K 0.93% 29
2025
Q4
$1.54M Buy
14,639
+56
+0.4% +$5.26K 0.86% 32
2025
Q3
$1.22M Buy
14,583
+283
+2% +$23.3K 0.74% 41
2025
Q2
$1.13M Buy
14,300
+2,313
+19% +$184K 0.76% 39
2025
Q1
$1.08M Buy
11,987
+3,521
+42% +$329K 0.77% 36
2024
Q4
$842K Buy
8,466
+2,232
+36% +$230K 0.65% 47
2024
Q3
$708K Hold
6,234
0.54% 53
2024
Q2
$772K Hold
6,234
0.65% 51
2024
Q1
$823K Buy
+6,234
New +$768K 0.69% 47

Other funds holding MRK

Keynote Financial Services's MRK Position: Q1 2026 in Review

Keynote Financial Services reduced its Merck (MRK) stake by 0.24% in Q1 2026, selling an estimated $4.04K and leaving 14,604 shares worth $1.76M. The position accounts for 0.93% of the portfolio, ranked #29.

Keynote Financial Services first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Keynote Financial Services held 14,604 shares of Merck worth $1.76M as of Q1 2026.
  • Keynote Financial Services sold 35 Merck shares in Q1 2026, an estimated $4.04K.
  • Merck made up 0.93% of Keynote Financial Services's portfolio in Q1 2026, its #29 holding.
  • Keynote Financial Services first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.